文章预览
各领域专家汇聚在BioSpark Monthly News论坛，交流过去一个月发生的 生物医药领域大事件 。 本月热点 TOPICS 1 . Oncology : AbbVie and Xilio announced multi-program collaboration on T cell engagers； Boehringer's zongertinib received FDA Priority Review for the treatment of HER2-mutant advanced NSCLC； MSKCC phase 1 study of mRNA neoantigen vaccines in pancreatic cancer showed induction of long-lived CD8 T cells; 2 . Autoimmune Diseases ： Cabaletta Bio’s CD19 CAR-T rese-cel showed clinical efficacy across multiple autoimmune indications； AnaptysBio’s Rosnilimab met primary endpoint across all dose levels in a phase 2b trial of rheumatoid arthritis; Sanofi & Teva unveiled new phase 2b data on anti-TL1A Duvakitug for two forms of IBD, positioning it as a competitor to Merck’s Tulisokibart; 3 . Other Topics ： Neurona Therapeutics announced plans for a phase 3 trial of NRTX-001 cell therapy in adults with drug-resistant mesial temp
………………………………
